FDA Clears Cingulate to File for Marketing Approval of
Phase 3 Data Collected to Date Sufficient for Submission of New Drug Application Advancing Discussions with Commercialization Partners...
Source: globenewswire.com
Stay updated with breaking news from Date Sufficient. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phase 3 Data Collected to Date Sufficient for Submission of New Drug Application Advancing Discussions with Commercialization Partners...
Phase 3 Data Collected to Date Sufficient for Submission of New Drug Application CTx-1301 Could Benefit >60% of ADHD Patients Currently ...